We are live on ! Find out more
T

TOBAM Portfolio holdings

AUM $384M
1-Year Est. Return 10.32%
This Fund
S&P 500
This Quarter Est. Return
+7.64%
1 Year Est. Return
+10.32%
3 Year Est. Return
+36.67%
5 Year Est. Return
+41.37%
10 Year Est. Return
+233.72%
AUM
$2.5B
AUM Growth
+$144M
Cap. Flow
+$16.9M
Cap. Flow %
0.68%
Top 10 Hldgs %
23.95%
Holding
453
New
26
Increased
85
Reduced
124
Closed
20

Top Buys

1
LLY icon
Eli Lilly
LLY
+$23M
2
NVAX icon
Novavax
NVAX
+$18.4M
3
IQ icon
iQIYI
IQ
+$17.4M
4
CBOE icon
Cboe Global Markets
CBOE
+$17M
5
NFLX icon
Netflix
NFLX
+$16.8M

Top Sells

1
SRPT icon
Sarepta Therapeutics
SRPT
+$27.7M
2
ROKU icon
Roku
ROKU
+$20.6M
3
SPG icon
Simon Property Group
SPG
+$16.5M
4
NIO icon
NIO
NIO
+$15.7M
5
MRNA icon
Moderna
MRNA
+$13.5M

Sector Composition

1 Consumer Staples 21.66%
2 Healthcare 21%
3 Consumer Discretionary 11.38%
4 Communication Services 9.41%
5 Materials 8.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NLY icon
126
Annaly Capital Management
NLY
$16.9B
$923K 0.04%
25,986
-57,820
-69% -$2.1M
CMCSA icon
127
Comcast
CMCSA
$84.9B
$877K 0.04%
15,387
– –
GME icon
128
GameStop
GME
$9.82B
$853K 0.03%
+15,928
New +$773K
KDP icon
129
Keurig Dr Pepper
KDP
$42.1B
$811K 0.03%
23,026
-69,682
-75% -$2.49M
FRT icon
130
Federal Realty Investment Trust
FRT
$10.9B
$794K 0.03%
6,780
-235
-3% -$26.7K
PFE icon
131
Pfizer
PFE
$143B
$771K 0.03%
19,701
– –
PEP icon
132
PepsiCo
PEP
$187B
$727K 0.03%
4,908
– –
KO icon
133
Coca-Cola
KO
$351B
$701K 0.03%
12,953
-731
-5% -$39.8K
CMG icon
134
Chipotle Mexican Grill
CMG
$44.2B
$691K 0.03%
22,300
-13,700
-38% -$391K
T icon
135
AT&T
T
$151B
$687K 0.03%
31,613
-1,819
-5% -$41.4K
TMO icon
136
Thermo Fisher Scientific
TMO
$198B
$680K 0.03%
1,347
– –
JOBS
137
DELISTED
51job Inc
JOBS
$678K 0.03%
8,718
+2,200
+34% +$154K
WSO icon
138
Watsco Inc
WSO
$15.3B
$677K 0.03%
2,363
+201
+9% +$57.5K
EGO icon
139
Eldorado Gold
EGO
$7.28B
$673K 0.03%
67,713
-130,457
-66% -$1.45M
MRK icon
140
Merck
MRK
$315B
$661K 0.03%
8,494
-408
-5% -$30.3K
ABBV icon
141
AbbVie
ABBV
$450B
$654K 0.03%
5,806
-345
-6% -$38.9K
WFC icon
142
Wells Fargo
WFC
$265B
$641K 0.03%
14,156
– –
CRWD icon
143
CrowdStrike
CRWD
$207B
$623K 0.02%
9,920
-644
-6% -$34.6K
MCD icon
144
McDonald's
MCD
$190B
$577K 0.02%
2,496
-168
-6% -$39.1K
COST icon
145
Costco
COST
$417B
$576K 0.02%
1,456
-102
-7% -$38.6K
ABT icon
146
Abbott
ABT
$175B
$570K 0.02%
4,919
+1,264
+35% +$147K
DHR icon
147
Danaher
DHR
$144B
$569K 0.02%
2,394
+798
+50% +$177K
ASND icon
148
Ascendis Pharma A/S
ASND
$17.1B
$535K 0.02%
4,069
+907
+29% +$121K
TSN icon
149
Tyson Foods
TSN
$20.3B
$519K 0.02%
7,034
+536
+8% +$41.6K
CTRA
150
DELISTED
Coterra Energy
CTRA
$483K 0.02%
27,667
-719,042
-96% -$12.2M
4 5
6
7 8

Similar funds

PCM
Pinnbrook Capital Management New York $384M AUM 147.48% 1-Year Est. Return
DFA
Delta Financial Advisors New Orleans, Louisiana $384M AUM 26.86% 1-Year Est. Return
BAMG
Brand Asset Management Group Chesterfield, Missouri $385M AUM 22.41% 1-Year Est. Return
DR
Davis Rea Toronto, Ontario, Canada $384M AUM 11.74% 1-Year Est. Return
GCP
Garda Capital Partners Wayzata, Minnesota $385M AUM 7.25% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
GA
GSG Advisors Mount Laurel, New Jersey $385M AUM 19.83% 1-Year Est. Return
VI
VectorGlobal IAG Miami, Florida $385M AUM

TOBAM's Q2 2021 Portfolio in Review

As of Q2 2021, TOBAM held 453 positions worth $2.5B, up 6.1% from $2.35B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

TOBAM's Q2 2021 filing shows 26 new, 85 increased, 124 reduced and 20 closed positions. Its largest new stake was GFL Environmental: 313,947 shares worth $10M. The largest sale was Sarepta Therapeutics, an estimated $27.7M.

By sector, the portfolio is most concentrated in Consumer Staples at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • TOBAM's largest Q2 2021 buy was GFL Environmental: 313,947 shares worth $10M.
  • TOBAM added most to Eli Lilly in Q2 2021, an estimated $23M increase.
  • TOBAM's biggest Q2 2021 reduction was Roku, cutting an estimated $20.6M.
  • TOBAM fully exited Sarepta Therapeutics in Q2 2021, selling an estimated $27.7M.
  • TOBAM's ten largest holdings make up 24% of its $2.5B portfolio in Q2 2021.
  • TOBAM opened 26 new positions and closed 20 in Q2 2021.
  • TOBAM's portfolio value rose 6.1% quarter-over-quarter to $2.5B.

Based on TOBAM's 13F filing for Q2 2021, filed 11 Aug 2021.